🔗 Permalink

Inventor profile of:

Bert Klebl

City:

Dortmund

Country:

Germany

Published Applications:

Last publication date:

2025-06-26

Top Assignees for applications by Bert Klebl

The entities that hold a legal rights for patent applications filed by inventor Klebl Bert:

LEAD DISCOVERY CENTER GMBH 7 DORTMUND, Germany
Bayer Intellectual Property GmbH 2 Monheim, Germany
Ingenium Pharmaceuticals GmbH 2 Martinsried, Germany
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e V. 1 Munchen, Germany
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 1 Munchen, Germany
Max Planck Gesellschaft zur Förderung der Wissenschften e.V. 1 Munich, Germany
MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCCHAFTEN E.V. 1 München, Germany
MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. 1 Muenchen, Germany
LEADDISCOVERY CENTER GMBH 1 Dortmund, Germany
MAX-PLANCK GESELLSCHAFTZUR FORDERUNG DER WIS SENSCHAFTEN E.V 1 Munchen, Germany
SOTIO a.s. 1 Prague, Czech Republic

Recent patent applications by Klebl Bert

Bert Klebl from Dortmund, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-26

US20250205242A1

Human necessities

CDK7 INHIBITORS FOR ANTIVIRAL TREATMENT

#2 | 2024-12-19

US20240415819A1

Human necessities

MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS

#3 | 2024-09-05

US20240294522A1

Chemistry; metallurgy

3-SUBSTITUTED 1H-PYRROLO[2,3-B]PYRIDINE AS GRK5 MODULATORS

#4 | 2024-08-01

US20240252454A1

Human necessities

COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION

#5 | 2022-11-24

US20220370440A1

Human necessities

4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER

#6 | 2020-09-17

US20200291011A1

Chemistry; metallurgy

Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

#7 | 2020-01-30

US20200031794A1

Chemistry; metallurgy

4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

#8 | 2015-11-19

US20150329537A2

Chemistry; metallurgy

CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA

#9 | 2014-10-09

US20140303167A1

Chemistry; metallurgy

CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA

#10 | 2014-10-02

US20140296304A1

Chemistry; metallurgy

Pharmaceutically active disubstituted pyridine derivatives

#11 | 2014-09-25

US20140287454A1

Physics

SUSCEPTIBILITY TO SELECTIVE CDK9 INHIBITORS

#12 | 2014-01-16

US20140018365A1

Chemistry; metallurgy

Pharmaceutically active compounds as Axl inhibitors

#13 | 2013-12-19

US20130338147A1

Chemistry; metallurgy

4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES

#14 | 2013-03-28

US20130079345A1

Chemistry; metallurgy

PHARMACEUTICALLY ACTIVE DISUBSTITUTED TRIAZINE DERIVATIVES

#15 | 2011-12-15

US20110306602A1

Chemistry; metallurgy

4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases

InventorID:

167455 ⎘